NewsBite

CSL tumbles as investors fear RFK jnr’s vaccine plans

Joshua Peach and Joanne Tran
Updated
EmailLinkedInTwitterFacebook

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

CSL tumbled to a six-month low on Monday as investors fled healthcare stocks after US President-elect Donald Trump named avowed vaccine sceptic Robert F. Kennedy jnr to lead the US Health Department.

Australia’s largest pharmaceutical group, which has manufactured seasonal influenza vaccines since the 1940s, is trading below $273 for the first time since April. The shares are down more than 4 per cent since Mr Kennedy’s nomination was announced on Friday.

Loading...
Joshua Peach is a data journalist at The Australian Financial Review Email Joshua at joshua.peach@nine.com.au
Joanne Tran is a markets reporter for The Australian Financial Review in the Sydney newsroom. Connect with Joanne on Twitter. Email Joanne at jo.tran@afr.com
EmailLinkedInTwitterFacebook

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

License article

Read More

Latest In Equity markets

Fetching latest articles

Most Viewed In Markets

    The Australian Financial Review Magazine

    From left: Michael Schumacher, Roger Federer, Ash Barty, Mark Webber and Daniel Ricciardo have all been in “commercial marriages” with watch brands.

    BOSS Financial Review

    Kim Feitelberg established her haircare company, HairShots, in early 2023.

    Life & Leisure

    Rich List

    Nick Andrianakos, pictured in Greece’s Nafplio, where he had been building a hotel.

    Original URL: https://www.afr.com/markets/equity-markets/csl-tumbles-as-investors-fear-rfk-jr-s-vaccine-plans-20241118-p5krft